Ory Rouvio
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
-
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology
Papers in
- Hematology 16
- Multiple Myeloma Research and Treatments 14
- Acute Myeloid Leukemia Research 2
- Genetics 7
- Chronic Lymphocytic Leukemia Research 6
- Co-authors
- Tamar Tadmor (9 shared papers)Moshe E. Gatt (7 shared papers)Hila Magen (6 shared papers)Irit Mazza Avivi (7 shared papers)Yael Chava Cohen (7 shared papers)Chezi Ganzel (4 shared papers)Evgeni Chubar (2 shared papers)Noa Lavi (4 shared papers)
- Journals
- Blood (4 papers)Leukemia Research (2 papers)Vaccine (1 paper)European Journal of Gastroenterology & Hepatology (1 paper)Journal of Cancer (1 paper)
- Partner nations
- IsraelUnited StatesItaly
In The Last Decade
Ory Rouvio
22 papers receiving 605 citations
Peers
Comparison fields: 5 of 57
- Hematology 394
- Oncology 211
- Genetics 66
- Molecular Biology 299
- Immunology 63
Countries citing papers authored by Ory Rouvio
This map shows the geographic impact of Ory Rouvio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ory Rouvio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ory Rouvio more than expected).
Fields of papers citing papers by Ory Rouvio
This network shows the impact of papers produced by Ory Rouvio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ory Rouvio. The network helps show where Ory Rouvio may publish in the future.
Co-authors
The 25 scholars most cited alongside Ory Rouvio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 195 | |
| 2 | 2021 | 180 | |
| 3 | 2012 | 63 | |
| 4 | 2015 | 36 | |
| 5 | 2015 | 22 | |
| 6 | 2020 | 18 | |
| 7 | 2020 | 18 | |
| 8 | 2018 | 14 | |
| 9 | 2018 | 13 | |
| 10 | 2022 | 12 | |
| 11 | 2005 | 11 | |
| 12 | 2018 | 8 | |
| 13 | 2020 | 5 | |
| 14 | 2019 | 3 | |
| 15 | 2016 | 3 | |
| 16 | 2022 | 2 | |
| 17 | 2020 | 2 | |
| 18 | 2015 | 1 | |
| 19 | 2017 | 1 | |
| 20 | 2022 | 1 |
About Ory Rouvio
Ory Rouvio is a scholar working on Hematology, Genetics, Pathology and Forensic Medicine, Oncology and Immunology, having authored 24 papers that have together received 611 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (14 papers), Protein Degradation and Inhibitors (7 papers), Lymphoma Diagnosis and Treatment (6 papers), Chronic Lymphocytic Leukemia Research (6 papers), Immunotherapy and Immune Responses (3 papers), Acute Myeloid Leukemia Research (2 papers), Viral-associated cancers and disorders (2 papers) and Ubiquitin and proteasome pathways (2 papers). The work is most often cited by research in Hematology (394 citations), Oncology (211 citations), Genetics (66 citations), Molecular Biology (299 citations) and Immunology (63 citations). Ory Rouvio has collaborated with scholars based in Israel, United States and Italy. Frequent co-authors include Tamar Tadmor, Moshe E. Gatt, Hila Magen, Irit Mazza Avivi, Yael Chava Cohen, Chezi Ganzel, Evgeni Chubar, Noa Lavi, Angel Porgador and Tzippy Shochat. Their work appears in journals such as Blood, Leukemia Research, Vaccine, European Journal of Gastroenterology & Hepatology and Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.